{"id":5212,"date":"2023-04-20T18:37:57","date_gmt":"2023-04-20T16:37:57","guid":{"rendered":"https:\/\/adocia2.s18854168.onlinehome-server.info\/accueil\/"},"modified":"2026-01-13T18:08:59","modified_gmt":"2026-01-13T17:08:59","slug":"accueil","status":"publish","type":"page","link":"https:\/\/adocia2.s18854168.onlinehome-server.info\/fr\/","title":{"rendered":"Accueil"},"content":{"rendered":"

[vc_row content_placement=\u00a0\u00bbmiddle\u00a0\u00bb el_id=\u00a0\u00bbfirstimg\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1758107098261{background-image: url(https:\/\/adocia2.s18854168.onlinehome-server.info\/composants\/uploads\/2025\/09\/Adocia-2024-3-1.webp?id=22983) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}\u00a0\u00bb][vc_column][vc_row_inner el_class=\u00a0\u00bbcontainer\u00a0\u00bb][vc_column_inner el_class=\u00a0\u00bbfadeInLeft\u00a0\u00bb width=\u00a0\u00bb3\/4″ offset=\u00a0\u00bbvc_col-lg-7 vc_col-md-8″][vc_column_text el_class=\u00a0\u00bbmw-500″]<\/p>\n

Innovative medicine for everyone everywhere<\/h1>\n

[\/vc_column_text][vc_column_text]Adocia est une soci\u00e9t\u00e9 fran\u00e7aise de biotechnologie au stade clinique sp\u00e9cialis\u00e9e dans le d\u00e9veloppement de traitements innovants contre le diab\u00e8te et l\u2019ob\u00e9sit\u00e9.[\/vc_column_text]\n \n D\u00e9couvrir \"Arrow\n <\/a>\n \n [vc_column_text el_class=\u00a0\u00bbcstm-btn d-none\u00a0\u00bb]Augmentation de capital<\/strong>
\nConsulter les informations<\/a>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_section css=\u00a0\u00bb.vc_custom_1682343604200{background-image: url(https:\/\/adocia2.s18854168.onlinehome-server.info\/composants\/uploads\/2023\/04\/bg-related_point.jpg?id=36) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}\u00a0\u00bb][vc_row content_placement=\u00a0\u00bbmiddle\u00a0\u00bb el_class=\u00a0\u00bbcontainer\u00a0\u00bb][vc_column width=\u00a0\u00bb1\/2″][vc_column_text el_class=\u00a0\u00bbfadeInLeft\u00a0\u00bb]<\/p>\n

Produits
\n& plateformes<\/h2>\n

S’appuyant sur des technologies de rupture et de solides strat\u00e9gies de propri\u00e9t\u00e9 intellectuelle, les produits et plateformes d’Adocia vont des formulations innovantes de peptides et de prot\u00e9ines d\u00e9j\u00e0 approuv\u00e9s aux implants immunoprotecteurs pour la th\u00e9rapie cellulaire.[\/vc_column_text][\/vc_column][vc_column width=\u00a0\u00bb1\/2″]\n

\n \n Nous contacter \"Arrow\n <\/a>\n <\/div>\n \n [\/vc_column][\/vc_row][\/vc_section][vc_row el_class=\u00a0\u00bbcontainer block-separator\u00a0\u00bb][vc_column][vc_row_inner][vc_column_inner el_class=\u00a0\u00bbblock_link_container three-column\u00a0\u00bb]\n
\n \n \"\"
\n Pipeline<\/span>\n voir plus<\/span>\n <\/div>\n <\/a>\n <\/div>\n\n \n
\n \n \"\"
\n Plateformes technologiques<\/span>\n voir plus<\/span>\n <\/div>\n <\/a>\n <\/div>\n\n [\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_section content_placement=\u00a0\u00bbmiddle\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1682342825505{background-image: url(https:\/\/adocia2.s18854168.onlinehome-server.info\/composants\/uploads\/2023\/04\/bg-drawing-1.jpg?id=41) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}\u00a0\u00bb el_class=\u00a0\u00bbmh-700″][vc_row el_class=\u00a0\u00bbcontainer\u00a0\u00bb][vc_column width=\u00a0\u00bb7\/12″ offset=\u00a0\u00bbvc_col-md-offset-6 vc_col-md-6 vc_col-sm-offset-5 vc_col-xs-offset-3 vc_col-xs-9″ el_class=\u00a0\u00bbfadeInRight text-right text-sm-left\u00a0\u00bb][vc_column_text]<\/p>\n

Pr\u00e9sentation
\nd’Adocia<\/h2>\n

Depuis sa cr\u00e9ation par la famille Soula en 2005, Adocia a d\u00e9velopp\u00e9 une expertise unique dans le domaine du diab\u00e8te et de l’ob\u00e9sit\u00e9. La priorit\u00e9 d’Adocia est de d\u00e9velopper des formulations innovantes d’insulines et d’autres hormones m\u00e9taboliques. Avec la volont\u00e9 de devenir un acteur incontournable des traitements hormonaux, Adocia a mis en place un pipeline diversifi\u00e9 de produits de sp\u00e9cialit\u00e9 destin\u00e9s au traitement du diab\u00e8te de type 1 et de type 2 ainsi qu’\u00e0 celui de l’ob\u00e9sit\u00e9.[\/vc_column_text]\n \n D\u00e9couvrir \"Arrow\n <\/a>\n \n [\/vc_column][\/vc_row][\/vc_section][vc_section content_placement=\u00a0\u00bbmiddle\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1682439595837{background-image: url(https:\/\/adocia2.s18854168.onlinehome-server.info\/composants\/uploads\/2023\/04\/bg-drawing-2.jpg?id=43) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}\u00a0\u00bb el_class=\u00a0\u00bbmh-xl-700″][vc_row el_class=\u00a0\u00bbcontainer\u00a0\u00bb][vc_column width=\u00a0\u00bb2\/3″ offset=\u00a0\u00bbvc_col-md-6 vc_col-xs-10″ el_class=\u00a0\u00bbfadeInLeft\u00a0\u00bb][vc_column_text]<\/p>\n

Partenariat<\/h2>\n

Adocia octroie des licences pour ses produits et technologies apr\u00e8s en avoir \u00e9tabli la preuve de concept chez l’homme. Int\u00e9ress\u00e9 par un partenariat avec nous ? N’h\u00e9sitez pas \u00e0 nous contacter ![\/vc_column_text]\n \n Voir plus \"Arrow\n <\/a>\n \n [\/vc_column][\/vc_row][\/vc_section][vc_section el_class=\u00a0\u00bbbg-grey\u00a0\u00bb][vc_row el_class=\u00a0\u00bbcontainer\u00a0\u00bb][vc_column][vc_column_text el_class=\u00a0\u00bbfadeInBottom\u00a0\u00bb]<\/p>\n

M\u00e9dias<\/h2>\n
\n
\n \n
\n
24 f\u00e9vrier 2026<\/div>\n \"Icon\n <\/div>\n
ADOCIA publie ses r\u00e9sultats financiers du quatri\u00e8me trimestre 2025 et fait le point sur ses activit\u00e9s<\/div>\n <\/a>\n \n
\n
18 d\u00e9cembre 2025<\/div>\n \"Icon\n <\/div>\n
ADOCIA annonce son calendrier financier pour l\u2019ann\u00e9e 2026<\/div>\n <\/a>\n \n
\n
4 d\u00e9cembre 2025<\/div>\n \"Icon\n <\/div>\n
ADOCIA annonce la r\u00e9alisation d\u2019une lev\u00e9e de fonds de 10 millions d\u2019euros<\/div>\n <\/a>\n \n
\n
12 novembre 2025<\/div>\n \"Icon\n <\/div>\n
ADOCIA annonce le d\u00e9p\u00f4t de brevet d\u2019une nouvelle plateforme de peptides \u00e0 action prolong\u00e9e pour le diab\u00e8te et l\u2019ob\u00e9sit\u00e9 – AdoXLong – et fait le point sur sa plateforme BioChaperone\u00ae<\/div>\n <\/a>\n \n
\n
15 octobre 2025<\/div>\n \"Icon\n <\/div>\n
ADOCIA publie ses r\u00e9sultats financiers du troisi\u00e8me trimestre 2025 et fait le point sur ses activit\u00e9s<\/div>\n <\/a>\n \n
\n
15 octobre 2025<\/div>\n \"Icon\n <\/div>\n
ADOCIA et Tonghua Dongbao annoncent les r\u00e9sultats positifs de l’essai clinique de Phase 3 sur l’insuline ultra-rapide BioChaperone\u00ae Lispro (THDB0206 injection) chez les personnes atteintes de Diab\u00e8te de Type 1<\/div>\n <\/a>\n <\/div>\n
\n Voir tout<\/a>\n <\/div>\n <\/div>\n\n [\/vc_column_text][\/vc_column][\/vc_row][\/vc_section]<\/p>\n<\/section>","protected":false},"excerpt":{"rendered":"

[vc_row content_placement=\u00a0\u00bbmiddle\u00a0\u00bb el_id=\u00a0\u00bbfirstimg\u00a0\u00bb css=\u00a0\u00bb.vc_custom_1758107098261{background-image: url(https:\/\/adocia2.s18854168.onlinehome-server.info\/composants\/uploads\/2025\/09\/Adocia-2024-3-1.webp?id=22983) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}\u00a0\u00bb][vc_column][vc_row_inner el_class=\u00a0\u00bbcontainer\u00a0\u00bb][vc_column_inner el_class=\u00a0\u00bbfadeInLeft\u00a0\u00bb width=\u00a0\u00bb3\/4″ offset=\u00a0\u00bbvc_col-lg-7 vc_col-md-8″][vc_column_text el_class=\u00a0\u00bbmw-500″] Innovative medicine for everyone everywhere [\/vc_column_text][vc_column_text]Adocia est […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/adocia2.s18854168.onlinehome-server.info\/fr\/wp-json\/wp\/v2\/pages\/5212"}],"collection":[{"href":"https:\/\/adocia2.s18854168.onlinehome-server.info\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/adocia2.s18854168.onlinehome-server.info\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/adocia2.s18854168.onlinehome-server.info\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/adocia2.s18854168.onlinehome-server.info\/fr\/wp-json\/wp\/v2\/comments?post=5212"}],"version-history":[{"count":22,"href":"https:\/\/adocia2.s18854168.onlinehome-server.info\/fr\/wp-json\/wp\/v2\/pages\/5212\/revisions"}],"predecessor-version":[{"id":23901,"href":"https:\/\/adocia2.s18854168.onlinehome-server.info\/fr\/wp-json\/wp\/v2\/pages\/5212\/revisions\/23901"}],"wp:attachment":[{"href":"https:\/\/adocia2.s18854168.onlinehome-server.info\/fr\/wp-json\/wp\/v2\/media?parent=5212"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}